Gene Therapy Market Research Reports & Industry Analysis
Gene therapy is an innovative field with the potential to develop new, personalized medical treatments for previously challenging conditions. At MarketResearch.com, we are committed to providing you with comprehensive gene therapy industry reports that shed light on this fast-growing market.
Understanding the Gene Therapy Market
- Our gene therapy market research reports provide valuable insights into this dynamic field to help you understand the key factors at play, prepare for challenges, and leverage technological advancements.
- Our research collection covers various markets—such as gene therapy, precision medicine, delivery devices, and manufacturing services—with data on market size and growth projections.
- In addition, we also delve into market segmentation, key developments, industry trends, and company profiling to give you the full picture of the market.
Helping You Stay Ahead
Whether you're an experienced industry professional, a consultant, or a busy executive, our gene therapy market research reports provide valuable insights. These reports are based on reliable data and expert analysis to help you make informed business decisions. With MarketResearch.com, you can stay ahead of the competition and take advantage of emerging market opportunities.
Gene Therapy Industry Research & Market Reports
-
Middle East & Africa Microcarriers Market Forecast to 2030 - Regional Analysis - by Product (Media & Reagents and Microcarrier Beads), Equipment (Bioreactors, Culture Vessels, and Others), Application (Biopharmaceutical Production, Cell and Gene Therapy, Tissue Engineering and Regenerative Medicine, and Others), and End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations, and Academic & Research Institutes)
... Engineering and Regenerative Medicine, and Others), and End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations, and Academic & Research Institutes) The Middle East & Africa microcarriers market is expected to ... Read More
-
Asia Pacific Microcarriers Market Forecast to 2030 - Regional Analysis - by Product (Media & Reagents and Microcarrier Beads), Equipment (Bioreactors, Culture Vessels, and Others), Application (Biopharmaceutical Production, Cell and Gene Therapy, Tissue Engineering and Regenerative Medicine, and Others), and End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations, and Academic & Research Institutes)
... Regenerative Medicine, and Others), and End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations, and Academic & Research Institutes) The Asia Pacific microcarriers market is expected to grow from US$ 366.14 ... Read More
-
South & Central America Microcarriers Market Forecast to 2030 - Regional Analysis - by Product (Media & Reagents and Microcarrier Beads), Equipment (Bioreactors, Culture Vessels, and Others), Application (Biopharmaceutical Production, Cell and Gene Therapy, Tissue Engineering and Regenerative Medicine, and Others), and End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations, and Academic & Research Institutes)
... Engineering and Regenerative Medicine, and Others), and End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations, and Academic & Research Institutes) The South & Central America microcarriers market is expected to ... Read More
-
North America Microcarriers Market Forecast to 2030 - Regional Analysis - by Product (Media & Reagents and Microcarrier Beads), Equipment (Bioreactors, Culture Vessels, and Others), Application (Biopharmaceutical Production, Cell and Gene Therapy, Tissue Engineering and Regenerative Medicine, and Others), and End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations, and Academic & Research Institutes)
... Regenerative Medicine, and Others), and End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations, and Academic & Research Institutes) The North America microcarriers market is expected to grow from US$ 736.67 ... Read More
-
Biological Safety Testing Market – By Product and Services (Consumables, Instruments, Services, Reagents & Kits), Application (Gene Therapy, Stem Cells), Test Type (Endotoxin Test, Sterility Test, Bioburden Tests) – Global Forecast (2024 – 2032)
... safety testing market size is set to register 13.6% CAGR during 2024-2032, driven by the rising regulatory scrutiny and stringent safety standards imposed by health authorities worldwide. Regulatory agencies, such as the FDA, EMA, and ... Read More
-
Cell and Gene Therapy Supply Chain Software Market
... COP, QMS, LMS and PMS), Mode of Deployment (On-premise Deployment and Cloud-based Deployment), Scale of Operation (Clinical Scale and Commercial Scale), Type of End-User (Pharmaceutical Companies, Cell Therapy Labs, Hospitals / Medical Centers and Research ... Read More
-
2024 Global Cell And Gene Therapy Clinical Trials Industry (2030 Outlook)
... (Wharry Sharpe Research) The Global Advanced Market Outlook reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market ... Read More
-
2024 Global Cancer Gene Therapy Market Industry (2030 Outlook)
... Global Advanced Market Outlook reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market and product shipments include ... Read More
-
2024 Global Cell And Gene Therapy Manufacturing Services Market Industry (2030 Outlook)
... 46 countries (Wharry Sharpe Research) The Global Advanced Market Outlook reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 ... Read More
-
Global Bone Morphogenetic Protein (BMP) 2 Market Research Report 2024
... a CAGR of 8.91% during 2024-2030. North American market for Bone Morphogenetic Protein (BMP) 2 is estimated to increase from $ 432.24 million in 2023 to reach $ 653 million by 2030, at a CAGR ... Read More
-
Cell Therapy and Gene Therapy Markets (Markets by Disease Type), 2023-2029
... in modern medicine, promising revolutionary treatments by treating the underlying genetic causes of disease and by genetically controlling the body's immune system. Recent years have seen an increase in new therapies and the pipeline indicates ... Read More
-
AAV vectors in gene therapy – Pipeline Insight, 2024
... therapy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the ... Read More
-
Cell and Gene Therapies in Ophthalmology
... pigmentosa (retinitis) and Leber congenital amaurosis (LCA), is marketed globally, and is the only gene therapy on the market within the ophthalmology space. All other marketed CGTs are cell therapies. Holostem Terapie Avanzate’s Holoclar is ... Read More
-
Cell Culture Market, By Product (Consumables, Instruments), By Application (Biopharmaceutical Production, Tissue Culture & Engineering, Toxicity Testing, Drug Development, Cell & Gene Therapy, and Others), By End User (Biopharmaceutical Companies, Hospitals & Diagnostic Laboratories, CMO & CRO, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... & CRO, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) The cell culture market has seen significant growth in the last few decades driven by advancements in biomedical ... Read More
-
Spinal Muscular Atrophy Market, by Type (Type I, Type II, Type III, and Type IV), by Treatment (Gene Therapy and Disease-modifying drugs), by Age Group (Infant and Adult), by Route of Administration (Oral and Injectables), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031
... by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031 Spinal ... Read More
-
Global Cell and Gene Therapy Market
... type, product, application, and region. BCC determines the current market status in each segment, examines its impact on future needs, and presents growth forecasts over the next five years. The report provides a detailed analysis ... Read More
-
Cell and Gene Therapies in CNS Disorders
... therapies, and three conditionally approved cell therapies. Novartis’s Zolgensma (onasemnogene abeparvovec) for the treatment of spinal muscular atrophy (SMA) was the first CGT asset to receive traditional approval in the CNS market in 2019. Over ... Read More
-
2024 Global: Cancer Gene Therapy Market - Innovative Markets Forecast (2030) report
... the period 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 ... Read More
-
Microcarrier Market Analysis and Forecast to 2033: By Product (Consumables and Equipment), Application (Biopharmaceutical Production, Cell & Gene Therapy, Tissue Engineering, and Others), End-User (Pharmaceutical & Biotechnology Companies, Research Institutes, and Others), and Region
... microcarrier is a small particle, typically ranging in size from 0.1 to 10 micrometers, that can be used to culture cells in suspension. Microcarriers are usually made of polystyrene, glass, or other biocompatible materials, and ... Read More
-
2024 Global: Cell And Gene Therapy Clinical Trials - Innovative Markets Forecast (2030) report
... and regional data for the period 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions ... Read More
-
Biological Safety Testing Market Size, Trends, Analysis, and Outlook By Product & Services (Consumables, Instrument, Services), By Application (Vaccine Development and Manufacturing, Monoclonal Antibodies Development and Manufacturing, Cellular & Gene Therapy Products Development and Manufacturing, Blood and Blood Products Development and Manufacturing, Others), By Test (Endotoxin Test, Sterility Test, Mycoplasma Tests, Bioburden Tests, Residual Host-cell Proteins & DNA Detection Tests, Virus safety Test, Others), by Region, Country, Segment, and Companies, 2024-2030
... Blood and Blood Products Development and Manufacturing, Others), By Test (Endotoxin Test, Sterility Test, Mycoplasma Tests, Bioburden Tests, Residual Host-cell Proteins & DNA Detection Tests, Virus safety Test, Others), by Region, Country, Segment, and Companies, ... Read More
-
Cancer Biologics Market Size, Trends, Analysis, and Outlook By Product (Monoclonal antibodies, Cell and gene therapy, Vaccines, Others), By Route of Administration (Injectable, Oral), by Region, Country, Segment, and Companies, 2024-2030
... market size is poised to register 9.88% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Cancer Biologics market By Product (Monoclonal ... Read More
-
Cell and Gene Therapy Market Size, Trends, Analysis, and Outlook By Type (Cell Therapy, Gene Therapy), By Gene Type, Gene silencing, Cell replacement, Gene augmentation, Others), By Cell Type (T-Cells, Stem Cells, Other), By Application (Oncology, Dermatology, Musculoskeletal, Genetic Disorders, Others), by Region, Country, Segment, and Companies, 2024-2030
... (Oncology, Dermatology, Musculoskeletal, Genetic Disorders, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Cell and Gene Therapy market size is poised to register 20.38% growth (CAGR) from 2024 to 2030, presenting significant growth ... Read More
-
Primary Immunodeficiency Therapeutics Market Size, Trends, Analysis, and Outlook By Disease (Antibody Deficiency, Cellular Immunodeficiency, Innate Immune Disorders, Others), By Product (Immunoglobulin Replacement Therapy, Stem Cell/Bone Marrow Transplantation, Antibiotic Therapy, Gene Therapy, Others), by Region, Country, Segment, and Companies, 2024-2030
... Country, Segment, and Companies, 2024-2030 The global Primary Immunodeficiency Therapeutics market size is poised to register 7.55% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry ... Read More
-
Solid Tumors Drugs Market Size, Trends, Analysis, and Outlook By Type (Small Molecules, Biologics (Enzymes, Blood and Blood Components, Gene Therapy, Recombinant Proteins, Somatic Cells, Tissues, Vaccines)), By Application (Oncology, Radiology, Neurology, Others), by Region, Country, Segment, and Companies, 2024-2030
... Country, Segment, and Companies, 2024-2030 The global Solid Tumors Drugs market size is poised to register 15.96% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry ... Read More
Research Assistance
